Pleno recently came out of Stealth and announced a $15M round for their seemingly PCR-like but not PCR platform. There’s almost no information available…
After my post on Qitan there were a few comments on twitter that I thought might be worth addressing. The first suggested that “this is not an ASIC…
I’ve recently looked at 4 Chinese nanopore sequencing startups: AxBio, Genvida, RH Genetech, and Qitan Technology. In this post I’m going to briefly…
The final, and potentially most interesting of the three Chinese nanopore startups I’ve recently been looking at is Qitan Technology. For a nanopore…
While looking into Chinese nanopore companies I came across RH Genetech. The company appears to sell a number of instruments including air sampling LAMP…
This week I’m planning to look at a few different Chinese nanopore sequencing startups. There are in fact, a surprising number of them. I’ve previously…
A few things came up after my last post on Element. Firstly, over on twitter it was noted that Element have said they use a “multivalent binding…
UPDATE: Over on twitter, Simon Barnett pointed me toward this patent, which describes a related approach. Most of the conclusions in this post hold, but…
A few people have asked me about Elements’ recent announcements. You can find an excellent overview of the launch at OmicsOmics. For my own part (which…
Of Illumina’s recent announcements, Chemistry X seemed the most interesting to me. Not really because this is a significant leap forward, but because of…
In the first post on Reticula I described my fund raising adventures and in part 2 I described the motivation for low cost ($1 COGS, $500 instrument…
In my previous post I discussed the background to Reticula and all the fun I’ve had trying to fundraise. In this post I wanted to discuss COVID19 and…